Drug Trial Radar · NCT06524830
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
142
Actual
Start
Dec 30, 2024
Primary completion
Jul 30, 2026
Study completion Oct 16, 2026
Sponsor
- Lead sponsor
- atai Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 29, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase 2 study (protocol number VLS-01-203) will determine the efficacy, safety, and tolerability of short-term treatment with a VLS-01 transmucosal buccal film (VLS-01-BU) in patients with treatment resistant Major Depressive disorder (TRD) and will characterize the onset and durability of antidepressant effects of VLS-01-BU versus placebo.
Conditions
- Treatment Resistant Depression
Interventions
VLS-01-203 BUDrug
VLS-01 buccal transmucosal administration
VLS-01-BU PlaceboDrug
Placebo buccal transmucosal administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) total scoreTime frame: Baseline to Day 29
Locations
48 sites in 4 countries. Site status is shown where the registry gives one.
Noble Clinical Research
Tucson, Arizona
Pillar Clinical Research, LLC
Little Rock, Arkansas
Preferred Research Partners, Inc.
Little Rock, Arkansas
Woodland Research Northwest
Rogers, Arkansas
CenExel
Garden Grove, California
Behavioral Research Specialists, LLC
Glendale, California
Kadima Neuropsychiatry Institute
La Jolla, California
Collaborative Neuroscience Research, LLC
Los Alamitos, California
TRIP Clinical at Psychedelic Science Institute
Santa Monica, California
Mountain View Clinical Research Inc.
Denver, Colorado
CenExel
Hollywood, Florida
Bioresearch Partner
Miami, Florida
University of South Florida, Psychiatry and Behavioral Neurosciences
Tampa, Florida
CenExcel
Decatur, Georgia
CenExel
Savannah, Georgia
Pillar Clinical Research LLC
Chicago, Illinois
Sheppard Pratt
Baltimore, Maryland
Sunstone Medical, PC
Rockville, Maryland
Elixia MA
Springfield, Massachusetts
Adams Clinical
Watertown, Massachusetts
Institute for Integrative Therapies
Eden Prairie, Minnesota
Midwest Research Group
Saint Charles, Missouri
Clinilabs, LLC
Eatontown, New Jersey
Bio Behavioral Health
Toms River, New Jersey
The Medical Research Network, LLC
New York, New York
The Ohio State University
Columbus, Ohio
Neuro Behavioral Clinical Research, Inc.
North Canton, Ohio
Scranton Medical Institute, LLC
Moosic, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania
Biobehavioral Research of Austin
Austin, Texas
InSite Clinical Research
DeSoto, Texas
Aim Trials, LLC
Plano, Texas
Cedar Clinical Research Inc
Draper, Utah
Seattle Neuropsychiatric Treatment Center
Bellevue, Washington
Sydney Local Health District (SLHD) Mental Health
Camperdown, New South Wales, Australia
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
NeuroCentrix
Carlton, Victoria, Australia
The University of Melbourne
Carlton, Victoria, Australia
Royal Melbourne Hospital
Melbourne, Victoria, Australia
Paratus Clinical Research Melbourne
Northcote, Victoria, Australia
Showing 40 of 48 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.